Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9156 patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9156 patients

Published:2013-10-21 Issue:1 Volume:13 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Schwentner Lukas, ,Wöckel Achim,König Jochem,Janni Wolfgang,Ebner Florian,Blettner Maria,Kreienberg Rolf,Van Ewijk Reyn

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-13-487.pdf

Reference27 articles.

1. Badve S, Dabbs DJ, Schnitt SJ, Baehner SL, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR, Palacios J, Rakha EA, Richardson AL, Schmitt FC, Tan PH, Tse GM, Weigelt B, Ellis IO, Reis-Filho JS: Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol. 2011, 24 (2): 157-167. 10.1038/modpathol.2010.200.

2. Rakha EA, Ellis IO: Triple-negative/basal-like breast cancer: review. Pathology. 2009, 41 (1): 40-47. 10.1080/00313020802563510.

3. Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO: Prognostic markers in triple-negative breast cancer. Cancer. 2007, 109 (1): 25-32. 10.1002/cncr.22381.

4. Hudis CA, Gianni L: Triple-negative breast cancer: an unmet medical need. Oncologist. 2011, 16 (1): 1-11. 10.1634/theoncologist.2010-0301.

5. Teng YH, Thike AA, Wong NS, Tan PH: Therapeutic targets in triple negative breast cancer-where are we now?. Recent Pat Anticancer Drug Discov. 2011, 6 (2): 196-209. 10.2174/157489211795328521.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system;Breast Cancer Research and Treatment;2024-08-16

2. Tumor Characteristics Associated with Axillary Nodal Positivity in Triple Negative Breast Cancer;Diseases;2023-09-08

3. Implications for surveillance for breast cancer patients based on the internally and externally validated BRENDA-metastatic recurrence score;Breast Cancer Research and Treatment;2023-03-14

4. Improved guideline adherence in oncology through clinical decision-support systems: still hindered by current health IT infrastructures?;Current Opinion in Oncology;2022-11-11

5. Do hospital type or caseload make a difference in chemotherapy treatment patterns for early breast cancer? Results from 104 German institutions, 2008–2017;The Breast;2021-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3